These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23906381)

  • 1. Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B.
    Tarosso LF; Sanabani SS; Ribeiro SP; Sauer MM; Tomiyama HI; Sucupira MC; Diaz RS; Sabino EC; Kalil J; Kallas EG
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):190-4. PubMed ID: 23906381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection.
    Cornelissen M; Pasternak AO; Grijsen ML; Zorgdrager F; Bakker M; Blom P; Prins JM; Jurriaans S; van der Kuyl AC
    Clin Infect Dis; 2012 Feb; 54(4):539-47. PubMed ID: 22157174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
    Gray CM; Williamson C; Bredell H; Puren A; Xia X; Filter R; Zijenah L; Cao H; Morris L; Vardas E; Colvin M; Gray G; McIntyre J; Musonda R; Allen S; Katzenstein D; Mbizo M; Kumwenda N; Taha T; Karim SA; Flores J; Sheppard HW
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):285-91. PubMed ID: 15943570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
    Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
    PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.
    Paraskevis D; Touloumi G; Bakoyannis G; Paparizos V; Lazanas M; Gargalianos P; Chryssos G; Antoniadou A; Psichogiou M; Panos G; Katsarou O; Sambatakou H; Kordossis T; Hatzakis A;
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):461-9. PubMed ID: 23034083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.
    Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
    HIV Med; 2013 Jul; 14(6):362-9. PubMed ID: 23433434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of HIV-1 non-B subtype infections in Northwest Poland.
    Parczewski M; Leszczyszyn-Pynka M; Bander D; Urbańska A; Stańczak G; Boroń-Kaczmarska A
    J Med Virol; 2010 Aug; 82(8):1306-13. PubMed ID: 20578066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
    Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
    Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorer immunologic outcome on treatment among patients infected with HIV-1 non-B subtypes compared with subtype B in Singapore.
    Lee LK; Lin L; Chua A; Leo YS; Ng OT
    Clin Infect Dis; 2012 Jun; 54(12):1818-20. PubMed ID: 22423124
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
    J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness.
    Bocket L; Cheret A; Deuffic-Burban S; Choisy P; Gerard Y; de la Tribonnière X; Viget N; Ajana F; Goffard A; Barin F; Mouton Y; Yazdanpanah Y
    Antivir Ther; 2005; 10(2):247-54. PubMed ID: 15865219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).
    de Brito A; Komninakis SC; Novoa P; de Oliveira RM; Fonseca LA; Duarte AJ; Casseb J
    Clin Infect Dis; 2006 Dec; 43(11):1476-81. PubMed ID: 17083025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in São Paulo, Brazil.
    Sanabani S; Kleine Neto W; Kalmar EM; Diaz RS; Janini LM; Sabino EC
    Infect Genet Evol; 2006 Sep; 6(5):368-77. PubMed ID: 16522378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
    Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
    Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in HIV type 1 RNA plasma load profile of closely related cocirculating Ethiopian subtype C strains: C and C'.
    Ayele W; Mekonnen Y; Messele T; Mengistu Y; Tsegaye A; Bakker M; Berkhout B; Dorigo-Zetsma W; Wolday D; Goudsmit J; Coutinho R; de Baar M; Paxton WA; Pollakis G
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):805-13. PubMed ID: 20624072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic characteristics of HIV type 1 based on gp120 hypervariable region 3 of isolates from Southern Brazil.
    Franca RF; Castro-Jorge LA; Neto RJ; Jorge DM; Lima DM; Colares JK; Paula SO; da Fonseca BA
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):903-9. PubMed ID: 21087177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
    Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
    J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.